Ticker brief
JAZZ
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
22
authors 14d
15
crowd 14d
+0.6σ
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-08-17 → 2026-08-27 · now +0.00 (−1 bearish … +1 bullish)
Who spoke15
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @BiopharmIQ | B | · | 4 | +0.16 |
| @_TP888 | C | -1.12 | 3 | +0.50 |
| @MartyChargin | C | -0.27 | 2 | +0.15 |
| @CrweWorld | C | · | 2 | -0.03 |
| @Financhle | C | · | 1 | -0.45 |
| @markflowchatter | B | +2.00 | 1 | -0.10 |
| @BPharmCatalyst | C | · | 1 | +0.00 |
| @OpenOutcrier | C | · | 1 | +0.30 |
| @cnfinancewatch | B | -1.92 | 1 | +0.00 |
| @Omnitrader69 | C | -1.39 | 1 | -0.15 |
| @alphaticaio | B | -1.02 | 1 | +0.80 |
| @AlexMarenco1 | C | -0.28 | 1 | +0.35 |
| @semodough | C | -3.01 | 1 | +0.40 |
| @fwpharma | B | +0.98 | 1 | +0.50 |
| @spluscollective | C | +0.46 | 1 | +0.50 |
Recent signals22of 22 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-27 | @CrweWorld | +0.00 | Jazz priced an upsized exchangeable-notes offering alongside ordinary-share repurchases. | · | tweet ↗ |
| 2026-08-26 | @MartyChargin | -0.15 | Reports a $1B exchangeable-note offering with a possible $225M share repurchase. | · | tweet ↗ |
| 2026-08-26 | @CrweWorld | -0.05 | Jazz announces a $1 billion exchangeable-notes offering alongside ordinary-share repurchases. | · | tweet ↗ |
| 2026-08-25 | @spluscollective | +0.50 | Market recap combines FDA news, earnings reaction and technical signals across four tickers. | · | tweet ↗ |
| 2026-08-25 | @fwpharma | +0.50 | Ziihera received FDA approval for first-line HER2-positive gastric cancer. | · | tweet ↗ |
| 2026-08-25 | @BiopharmIQ | +0.50 | FDA approved Ziihera combination regimens as first-line treatment for HER2-positive GEA. | · | tweet ↗ |
| 2026-08-25 | @semodough | +0.40 | Reports BofA's $307 target and Buy stance after FDA approval of Ziihera in first-line gastric cancer. | · | tweet ↗ |
| 2026-08-25 | @AlexMarenco1 | +0.35 | Flags JAZZ as a stock institutions are buying today, with evidence apparently in the chart. | · | tweet ↗ |
| 2026-08-25 | @_TP888 | +0.50 | Jazz won FDA approval for two advanced gastric-cancer regimens. | · | tweet ↗ |
| 2026-08-25 | @MartyChargin | +0.45 | Medical stocks are described as finding expected support and bouncing. | · | tweet ↗ |
| 2026-08-25 | @alphaticaio | +0.80 | Calls JAZZ 65.8% undervalued with a 12-month target of $424.44 | · | tweet ↗ |
| 2026-08-25 | @_TP888 | +0.50 | Jazz received FDA approval for two first-line Ziihera-containing regimens. | · | tweet ↗ |
| 2026-08-25 | @_TP888 | +0.50 | FDA approved two Ziihera-containing regimens for advanced HER2-positive gastroesophageal cancer. | · | tweet ↗ |
| 2026-08-24 | @Omnitrader69 | -0.15 | Expresses doubt about JAZZ's ability to complete an unspecified deal. | · | tweet ↗ |
| 2026-08-24 | @BiopharmIQ | +0.25 | Provides a watch list of four imminent FDA decisions and their investor setups. | · | tweet ↗ |
| 2026-08-23 | @cnfinancewatch | +0.00 | Lists dated FDA approvals and upcoming PDUFA decisions across a biotech catalyst basket. | · | tweet ↗ |
| 2026-08-21 | @BiopharmIQ | +0.00 | Reports MRNA's 177% move on positive Phase 3 endpoints and lists upcoming biotech catalysts. | · | tweet ↗ |
| 2026-08-21 | @OpenOutcrier | +0.30 | Recaps positive and negative chatter and discrete catalysts across six stocks. | · | tweet ↗ |
| 2026-08-21 | @BPharmCatalyst | +0.00 | Weekly watchlist highlights biotech names with remaining quarterly PDUFA catalysts. | · | tweet ↗ |
| 2026-08-21 | @markflowchatter | -0.10 | Reports JAZZ and an unnamed $40 billion US biotech as two bidders. | · | tweet ↗ |
| 2026-08-17 | @Financhle | -0.45 | Reports a $950K aggressive purchase of $240 Jazz puts expiring September 18. | · | tweet ↗ |
| 2026-08-17 | @BiopharmIQ | -0.10 | Weekly biotech digest reports merger, trial, acquisition and competitive developments across named firms. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.